Cargando…

Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory

AIMS: This study aims to compare estimates of primary liver cancer mortality from World Health Organization (WHO), Global Burden Disease (GBD) and Global Cancer Observatory (GCO). METHODS: Liver cancer mortality was extracted from WHO, GBD and GCO for 92 countries for the most recent year. Age‐stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenxi, He, Wen‐Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543750/
https://www.ncbi.nlm.nih.gov/pubmed/35779247
http://dx.doi.org/10.1111/liv.15357
_version_ 1784804447661064192
author Li, Chenxi
He, Wen‐Qiang
author_facet Li, Chenxi
He, Wen‐Qiang
author_sort Li, Chenxi
collection PubMed
description AIMS: This study aims to compare estimates of primary liver cancer mortality from World Health Organization (WHO), Global Burden Disease (GBD) and Global Cancer Observatory (GCO). METHODS: Liver cancer mortality was extracted from WHO, GBD and GCO for 92 countries for the most recent year. Age‐standardized rate (ASR) was computed and used for current comparisons across the three data sources. Temporal trend for 75 countries was analysed and compared between WHO and GBD from 1990 to 2019 using joinpoint regression. Average annual percentage change for the most recent 10 years was used as indicator for change. RESULTS: The estimates of ASR were quite consistent across the three data sources, but most similar estimates were found between WHO and GCO in both region and country levels. The differences in ASR were negatively correlated with completeness of cause‐of‐death registration, human development index and proportion of liver cancer because of alcohol consumption. Consistent trends of ASR were found from 35 countries between WHO and GBD in the most recent 10 years. However, opposite trends were found from 10 countries with five from Southern America, four from Europe and one from Asia. Of the 18 countries for projection, opposite trends between WHO and GBD were found from seven countries. CONCLUSION: While the ASR of primary liver cancer mortality was comparable across the three data sources, most similar estimates were found between WHO and GCO. The opposite trends found from 10 countries between WHO and GBD raised concerns of true patterns in these countries.
format Online
Article
Text
id pubmed-9543750
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95437502022-10-14 Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory Li, Chenxi He, Wen‐Qiang Liver Int Liver Cancer AIMS: This study aims to compare estimates of primary liver cancer mortality from World Health Organization (WHO), Global Burden Disease (GBD) and Global Cancer Observatory (GCO). METHODS: Liver cancer mortality was extracted from WHO, GBD and GCO for 92 countries for the most recent year. Age‐standardized rate (ASR) was computed and used for current comparisons across the three data sources. Temporal trend for 75 countries was analysed and compared between WHO and GBD from 1990 to 2019 using joinpoint regression. Average annual percentage change for the most recent 10 years was used as indicator for change. RESULTS: The estimates of ASR were quite consistent across the three data sources, but most similar estimates were found between WHO and GCO in both region and country levels. The differences in ASR were negatively correlated with completeness of cause‐of‐death registration, human development index and proportion of liver cancer because of alcohol consumption. Consistent trends of ASR were found from 35 countries between WHO and GBD in the most recent 10 years. However, opposite trends were found from 10 countries with five from Southern America, four from Europe and one from Asia. Of the 18 countries for projection, opposite trends between WHO and GBD were found from seven countries. CONCLUSION: While the ASR of primary liver cancer mortality was comparable across the three data sources, most similar estimates were found between WHO and GCO. The opposite trends found from 10 countries between WHO and GBD raised concerns of true patterns in these countries. John Wiley and Sons Inc. 2022-07-09 2022-10 /pmc/articles/PMC9543750/ /pubmed/35779247 http://dx.doi.org/10.1111/liv.15357 Text en © 2022 The Authors. Liver International published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Liver Cancer
Li, Chenxi
He, Wen‐Qiang
Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
title Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
title_full Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
title_fullStr Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
title_full_unstemmed Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
title_short Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory
title_sort comparison of primary liver cancer mortality estimates from world health organization, global burden disease and global cancer observatory
topic Liver Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543750/
https://www.ncbi.nlm.nih.gov/pubmed/35779247
http://dx.doi.org/10.1111/liv.15357
work_keys_str_mv AT lichenxi comparisonofprimarylivercancermortalityestimatesfromworldhealthorganizationglobalburdendiseaseandglobalcancerobservatory
AT hewenqiang comparisonofprimarylivercancermortalityestimatesfromworldhealthorganizationglobalburdendiseaseandglobalcancerobservatory